SCHEMBL14671636

SCHEMBL14671636

COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C(F)=C\N(C)C

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.86
ERBB2 P04626 8/20 0.76
ERBB4 Q15303 3/20 0.76
GAK O14976 1/20 0.69
ABL1 P00519 1/20 0.64
PDGFRB P09619 1/20 0.64
SRC P12931 1/20 0.64
PDGFRA P16234 1/20 0.64
FLT3 P36888 1/20 0.64
HDAC3 O15379 1/20 0.62
HDAC4 P56524 1/20 0.62
HDAC1 Q13547 1/20 0.62
HDAC7 Q8WUI4 1/20 0.62
HDAC2 Q92769 1/20 0.62
HDAC10 Q969S8 1/20 0.62
HDAC11 Q96DB2 1/20 0.62
HDAC8 Q9BY41 1/20 0.62
HDAC6 Q9UBN7 1/20 0.62
HDAC9 Q9UKV0 1/20 0.62
HDAC5 Q9UQL6 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15877091 0.92 EGFR (1.00) EGFRERBB2ERBB4GAKABL1
SCHEMBL15877090 0.92 EGFR (1.00) EGFRERBB2ERBB4GAKABL1
SCHEMBL20395184 0.88 EGFR (0.85) EGFRERBB2ERBB4GAKHDAC3
SCHEMBL14671648 0.87 EGFR (0.76) EGFRERBB2ERBB4ABL1PDGFRB
SCHEMBL2525148 0.87 EGFR (0.86) EGFRERBB2ERBB4GAKHDAC2
SCHEMBL20412221 0.86 EGFR (0.82) EGFRERBB2ERBB4GAKHDAC3
SCHEMBL2251602 0.86 EGFR (0.87) EGFRERBB2ERBB4GAKHDAC3
SCHEMBL2544071 0.86 EGFR (0.83) EGFRERBB2ERBB4GAK
SCHEMBL2508012 0.86 EGFR (0.83) EGFRERBB2ERBB4GAK
SCHEMBL14671702 0.86 EGFR (0.82) EGFRERBB2ERBB4ABL1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013013640-A1 QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION AND APPLICATION THEREOF 上海医药集团股份有限公司 (CN) 2013-01-31 WO disclosed